Overview
To evaluate the efficacy and safety of ONO-1110 in Japanese patients with postherpetic neuralgia
Eligibility
Inclusion Criteria:
- Japanese (both sexes)
- Age (at the time of informed consent): 18 years and older
- Outpatient
- Patients with persistent pain ≥3 months (90 days) after the onset of herpes zoster
- Patients who are considered capable of understanding the study procedures and completing the pain diary and questionnaires appropriately by the investigator (sub-investigator)
Exclusion Criteria:
- Patients who previously underwent neurodestruction or neurosurgical therapy for PHN
- Patients with pain other than PHN that may affect assessments in this study
- Patients with any skin condition related to the site of herpes zoster that may affect assessments in this study
- Patients with a past history of or concurrent neurologic diseases that may affect assessments in this study
- Patients with concurrent psychiatric diseases that may affect assessments in this study